Stockreport

Flexion Therapeutics Names Melissa Layman Chief Commercial Officer

Flexion Therapeutics, Inc.  (FLXN) 
Last flexion therapeutics, inc. earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.flexiontherapeutics.com
PDF BURLINGTON, Mass., March 11, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Melissa Layman has been named Chief Commercial Offi [Read more]